Combination therapy with mineralocorticoid receptor antagonists and SGLT2 inhibitors in chronic kidney disease: an updated meta-analysis.

Kamido H, Hasebe M, Su CY, Sawa N, Yoshiji S

Open source

DOI
10.1093/joneph/aajag136
Published
2026 Aug 18
Container
Journal of nephrology
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1093/joneph/aajag136,
  title = {Combination therapy with mineralocorticoid receptor antagonists and SGLT2 inhibitors in chronic kidney disease: an updated meta-analysis.},
  author = {Kamido H and Hasebe M and Su CY and Sawa N and Yoshiji S},
  year = {2026},
  journal = {Journal of nephrology},
  doi = {10.1093/joneph/aajag136},
  url = {https://doi.org/10.1093/joneph/aajag136}
}

RIS

TY  - JOUR
TI  - Combination therapy with mineralocorticoid receptor antagonists and SGLT2 inhibitors in chronic kidney disease: an updated meta-analysis.
AU  - Kamido H
AU  - Hasebe M
AU  - Su CY
AU  - Sawa N
AU  - Yoshiji S
PY  - 2026
JO  - Journal of nephrology
DO  - 10.1093/joneph/aajag136
UR  - https://doi.org/10.1093/joneph/aajag136
ER  - 

APA

H, K., M, H., CY, S., N, S., & S, Y. (2026). Combination therapy with mineralocorticoid receptor antagonists and SGLT2 inhibitors in chronic kidney disease: an updated meta-analysis.. Journal of nephrology. https://doi.org/10.1093/joneph/aajag136

Source records